Influenza and pneumococcal vaccination protect against all cause mortality in patients with chronic obstructive pulmonary diseases

Aug-08

AUTHORS : Dr Stuart Schembri now works at The Australian National University, Canberra ACT 2600 Australia – Email: Stuart.Schembri@anu.edu.au – Profile: https://researchers.anu.edu.au/researchers/schembri-s

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 17(S1):194

DOI : 10.1002/pds.1631

Influenza and pneumococcal vaccination protect against all cause mortality in patients with chronic obstructive pulmonary diseases

More publications

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)